The significance of β2-adrenergic receptor polymorphisms in asthma

Current Opinion in Pulmonary Medicine

Volumn 12, Issue 1, 2006, Pages 12-17

  Litonjua, Augusto A ^a,b,c  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c NONE   (United States)

Author keywords

Association studies; Asthma; Polymorphism

Indexed keywords

ARGININE; BETA 2 ADRENERGIC RECEPTOR; BRONCHODILATING AGENT; GLUTAMIC ACID; GLYCINE; IPRATROPIUM BROMIDE; SALBUTAMOL;

ADRB2 GENE; ALLELE; ASTHMA; BRONCHUS HYPERREACTIVITY; CLINICAL TRIAL; DISEASE SEVERITY; DRUG RESPONSE; FORCED EXPIRATORY VOLUME; GENE; GENE FUNCTION; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; HAPLOTYPE; HUMAN; LUNG FUNCTION; NOCTURNAL ASTHMA; PHARMACOGENETICS; PHENOTYPE; PROMOTER REGION; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; META ANALYSIS; RISK FACTOR;

ASTHMA; GENETIC PREDISPOSITION TO DISEASE; HUMANS; META-ANALYSIS; PHARMACOGENETICS; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, ADRENERGIC, BETA-2; RISK FACTORS;

EID: 33646852406     PISSN: 10705287     EISSN: 15316971     Source Type: Journal    
DOI: 10.1097/01.mcp.0000198068.50457.95     Document Type: Review

References (63)

1. Sears MR, Lotvall J. Past, present and future: beta2-adrenoceptor agonists in asthma management. Respir Med 2005; 99:152-170.
2. Shelhamer JH, Marom Z, Kaliner M. Abnormal beta-adrenergic responsiveness in allergic subjects. II. The role of selective beta 2-adrenergic hyporeactivity. J Allergy Clin Immunol 1983; 71 (1 Pt 1):57-61.
3. Parker CW, Smith JW. Alterations in cyclic adenosine monophosphate metabolism in human bronchial asthma. I. Leukocyte responsiveness to beta-adrenergic agents. J Clin Invest 1973; 52:48-59.
4. Brooks SM, McGowan K, Bernstein IL, et al. Relationship between numbers of beta adrenergic receptors in lymphocytes and disease severity in asthma. J Allergy Clin Immunol 1979; 63:401-406.
5. Brooks SM, McGowan K, Altenau P. Relationship between beta-adrenergic binding in lymphocyte and severity of disease in asthma. Chest 1979; 75 (2 Suppl):232-283.
6. Galant SP, Duriseti L, Underwood S, Insel PA. Decreased beta-adrenergic receptors on polymorphonuclear leukocytes after adrenergic therapy. N Engl J Med 1978; 299:933-936.
7. Tashkin DP, Conolly ME, Deutsch RI, et al. Subsensitization of beta-adrenoceptors in airways and lymphocytes of healthy and asthmatic subjects. Am Rev Respir Dis 1982; 125:185-193.
8. Kobilka BK, Dixon RA, Frielle T, et al. cDNA for the human beta 2-adrenergic receptor: a protein with multiple membrane-spanning domains and encoded by a gene whose chromosomal location is shared with that of the receptor for platelet-derived growth factor. Proc Natl Acad Sci U S A 1987; 84:46-50.
9. Postma DS, Bleecker ER, Amelung PJ, et al. Genetic susceptibility to asthma: bronchial hyperresponsiveness coinherited with a major gene for atopy. N Engl J Med 1995; 333:894-900.
10. Bleecker ER, Amelung PJ, Levitt RC, et al. Evidence for linkage of total serum IgE and bronchial hyperresponsiveness to chromosome 5q: a major regulatory locus important in asthma. Clin Exp Allergy 1995; 25 (Suppl 2):84-88.
11. Ober C, Tsalenko A, Parry R, Cox NJ. A second-generation genomewide screen for asthma-susceptibility alleles in a founder population. Am J Hum Genet 2000; 67:1154-1162.
12. Reihsaus E, Innis M, MacIntyre N, Liggett SB. Mutations in the gene encoding for the beta 2-adrenergic receptor in normal and asthmatic subjects. Am J Respir Cell Mol Biol 1993; 8:334-339.
13. Green SA, Turki J, Innis M, Liggett SB. Amino-terminal polymorphisms of the human b2-adrenergic receptor impart distinct agonist-promoted regulatory properties. Biochemistry 1994; 33:9414-9419.
14. Green SA, Turki J, Bejarano P, et al. Influence of beta2-adrenergic receptor genotypes on signal transduction in humjan airway smooth muscle cells. Am J Respir Cell Mol Biol 1995; 13:25-33.
15. Moore PE, Laporte JD, Abraham JH, et al. Polymorphisms of the beta(2)-adrenergic receptor gene and desensitization in human airway smooth muscle. Am J Respir Crit Care Med 2000; 162:2117-2124.
16. McGraw DW, Forbes SL, Kramer LA, Liggett SB. Polymorphisms of the 50 leader cistron of the human beta2-adrenergic receptor regulate receptor expression. J Clin Invest 1998; 102:1927-1932.
17. Raby BA, Weiss ST. Beta2-adrenergic receptor genetics. Curr Opin Mol Ther 2001; 6:554-566.
18. Joos L, Pare PD, Sandford AJ. Beta(2)-Adrenergic receptor polymorphisms and asthma. Curr Opin Pulm Med 2001; 7:69-74.
19. Migita O, Noguchi E, Jian Z, et al. ADRB2 polymorphisms and asthma susceptibility: transmission disequilibrium test and meta-analysis. Int Arch Allergy Immunol 2004; 134:150-157. The authors perform a transmission- disequilibrium test analysis of three polymorphisms in ADRB2 in 137 Japanese families. There is no excess transmission of any of the alleles of the SNPs that they study. The authors then go on and perform a meta-analysis of nine additional association studies for the Arg16Gly and the Glu27Gln SNPs. They do not find an overall association with any of these SNPs and asthma diagnosis.
20. Contopoulos-Ioannidis DG, Manoli EN, Ioannidis JP. Meta-analysis of the association of beta2-adrenergic receptor polymorphisms with asthma phenotypes. J Allergy Clin Immunol 2005; 115:963-972. The authors perform a meta-analysis of the association of Arg16Gly and Glu27Gln with asthma diagnosis and asthma-related phenotypes. They conclude that there is no association between these two coding polymorphisms and either asthma diagnosis of airways hyperresponsiveness. They find an overall association, however, between Gly16 and both nocturnal asthma and asthma severity. Additionally, the authors show differences in allele frequencies between ethnic groups.
21. Thakkinstian A, McEvoy M, Minelli C, et al. Systematic review and metaanalysis of the association between β2-adrenoceptor polymorphisms and asthma: a HuGE review. Am J Epidemiol 2005; 162:201-211. The authors perform a meta-analysis of the association between Arg16Gly and Glu27Gln with asthma. The authors do not find an overall association with Arg16Gly, but find a weak association with the Glu27 allele. This is the only one of the three meta-analyses that pooled adult studies separately from childhood studies. They also document allele differences between ethnic groups. Significant heterogeneity was found between studies, and interestingly, the heterogeneity persisted when even when only Caucasian studies were included.
22. Lohmueller KE, Pearce CE, Pike M, et al. Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease. Nat Genet 2003; 33:177-182.
23. Santillan AA, Camargo CA, Ramirez-Rivera A, et al. Association between b2-adrenoceptor polymorphisms and asthma diagnosis among Mexican adults. J Allergy Clin Immunol 2003; 112:1095-1100.
24. Wang Z, Chen C, Niu T, et al. Association of asthma with beta(2)-adrenergic receptor gene polymorphism and cigarette smoking. Am J Respir Crit Care Med 2001; 163:1404-1409.
25. Holloway JW, Dunbar PR, Riley GA, et al. Association of beta2-adrenergic receptor polymorphisms with severe asthma. Clin Exp Allergy 2000; 30:1097-1103.
26. Gao G, Wang S, Zhang J. Study on beta 2 adrenergic receptor genetic polymorphisms in asthmatics in the people of the Han nationality of northern China. Zhonghua Jie He He Hu Xi Za Zhi 2000; 23:93-97.
27. Sato R. The role of beta 2-adrenoceptor gene polymorphisms in asthma. Hokkaido Igaku Zasshi 2000; 75:81-94.
28. Hopes E, McDougall C, Christie G, et al. Association of glutamine 27 polymorphism of beta 2 adrenoceptor with reported childhood asthma: population based study. BMJ 1998; 316:664.
29. Weir TD, Mallek N, Sandford AJ, et al. Beta2-Adrenergic receptor haplotypes in mild, moderate and fatal/near fatal asthma. Am J Respir Crit Care Med 1998; 158:787-791.
30. Martinez FD, Graves PE, Baldini M, et al. Association between genetic polymorphisms of the beta2-adrenoceptor and response to albuterol in children with and without a history of wheezing. J Clin Invest 1997; 100:3184-3188.
31. Binaei S, Christensen M, Murphy C, et al. Beta2-adrenergic receptor polymorphisms in children with status asthmaticus. Chest 2003; 123 (3 Suppl):375S.
32. Dewar JC, Wheatley AP, Venn A, et al. Beta2-adrenoceptor polymorphisms are in linkage disequilibrium, but are not associated with asthma in an adult population. Clin Exp Allergy 1998; 28:442-448.
33. Gao JM, Lin YG, Qiu CC, et al. Association of polymorphism of human beta 2-adrenergic receptor gene and bronchial asthma. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 2002; 24:626-631.
34. Kim SH, Oh SY, Oh HB, et al. Association of beta2-adrenoreceptor polymorphisms with nocturnal cough among atopic subjects but not with atopy and nonspecific bronchial hyperresponsiveness. J Allergy Clin Immunol 2002; 109:630-635.
35. Kotani Y, Nishimura Y, Maeda H, Yokoyama M. Beta2-adrenergic receptor polymorphisms affect airway responsiveness to salbutamol in asthmatics. J Asthma 1999; 36:583-590.
36. Lin YC, Lu CC, Shen CY, et al. Roles of genotypes of beta2-adrenergic receptor in the relationship between eosinophil counts and lung function in Taiwanese adolescents. J Asthma 2003; 40:265-272.
37. Shachor J, Chana Z, Varsano S, et al. Genetic polymorphisms of the beta-2 adrenergic receptor in Israelis with severe asthma compared to non-asthmatic Israelis. Isr Med Assoc J 2003; 5:821-824.
38. Turner SW, Khoo SK, Laing IA, et al. Beta2 adrenoceptor Arg16Gly polymorphism, airway responsiveness, lung function and asthma in infants and children. Clin Exp Allergy 2004; 34:1043-1048. This was an association study of a birth cohort of subjects who underwent lung function and airway responsiveness measurements at 1 month, 6 and 11 years of age.
39. Dai LM, Wang ZL, Zhang YP, et al. Relationship between the locus 16 genotype of beta 2 adrenergic receptor and the nocturnal asthma phenotype. Sichuan Da Xue Xue Bao Yi Xue Ban 2004; 35:32-34.
40. Turki J, Pak J, Green SA, Martin RJ, Liggett SB. Genetic polymorphisms of the beta 2-adrenergic receptor in nocturnal and nonnocturnal asthma. Evidence that Gly16 correlates with the nocturnal phenotype. J Clin Invest 1995; 95:1635-1641.
41. Fu J, Chen H, Hu L, et al. Association between the genetic polymorphisms of beta2-adrenergic receptor gene and the asthma susceptibility and clinical phenotypes in a Chinese population. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 2002; 19:41-45.
42. D'amato M, Vitiani LR, Petrelli G, et al. Association of persistent bronchial hyperresponsiveness with beta2-adrenoceptor (ADRB2) haplotypes. A population study. Am J Respir Crit Care Med 1998; 158:1968-1973.
43. Fowler SJ, Dempsey OJ, Sims EJ, Lipworth BJ. Screening for bronchial hyperresponsiveness using methacholine and adenosine monophosphate. Relationship to asthma severity and beta(2)-receptor genotype. Am J Respir Crit Care Med 2000; 162 (4 Pt 1):1318-1322.
44. Israel E, Drazen JM, Liggett SB, et al. The effect of polymorphisms of the beta(2)-adrenergic receptor on the response to regular use of albuterol in asthma. Am J Respir Crit Care Med 2000; 162:75-80.
45. Lipworth BJ, Hall IP, Tan S, et al. Effects of genetic polymorphism on ex vivo and in vivo function of beta2-adrenoceptors in asthmatic patients. Chest 1999; 115:324-328.
46. Litonjua AA, Silverman EK, Tantisira KG, et al. Beta2-adrenergic receptor plymorphisms and haplotypes are associated with airways hyperresponsiveness among nonsmoking men. Chest 2004; 126:66-74. This study showed that Arg16 was associated with airways hyperresponsiveness only among non-smoking men.
47. Ulbrecht M, Hergeth MT, Wjst M, et al. Association of beta(2)-adrenoreceptor variants with bronchial hyperresponsiveness. Am J Respir Crit Care Med 2000; 161 (2 Pt 1):469-474.
48. Winterton DL, Kaufman J, Keener CV, et al. Genetic polymorphisms as biomarkers of sensitivity to inhaled sulfur dioxide in subjects with asthma. Ann Allergy Asthma Immunol 2001; 86:232-238.
49. Hakonarson H, Bjornsdottir US, Ostermann E, et al. Allelic frequencies and patterns of single-nucleotide polymorphisms in candidate genes for asthma and atopy in Iceland. Am J Respir Crit Care Med 2001; 164:2036-2044.
50. Arnaiz NO, Kaufman JD, Daroowalla FM, et al. Genetic factors and asthma in aluminum smelter workers. Arch Environ Health 2003; 58:197-200.
51. Barr RG, Cooper DM, Speizer FE, et al. Beta(2)-adrenoceptor polymorphism and body mass index are associated with adult-onset asthma in sedentary but not active women. Chest 2001; 120:1474-1479.
52. Leung TF, Tang NL, Chan IH, et al. Distribution in allele frequencies of predisposition-to-atopy genotypes in Chinese children. Pediatr Pulmonol 2002; 34:419-424.
53. Silverman EK, Kwiatkowski DJ, Sylvia JS, et al. Family-based association analysis of beta2-adrenergic receptor polymorphisms in the childhood asthma management program. J Allergy Clin Immunol 2003; 112:870-876.
54. Horvath S, Xu X, Lake SL, et al. Family-based tests for associating haplotypes with general phenotype data: application to asthma genetics. Genet Epidemiol 2004; 26:61-69.
55. Tantisira KG, Weiss ST. The pharmacogenetics of asthma: an update. Curr Opin Mol Ther 2005; 7:209-217.
56. Choudhry S, Ung N, Avila PC, et al. Pharmacogenetic differences in response to albuterol between Puerto Ricans and Mexicans with asthma. Am J Respir Crit Care Med 2005; 171:563-570. A family-based and cross-sectional analysis of eight ADRB2 SNPs among Puerto Rican and Mexican asthmatics. The authors document different linkage disequilibrium patterns between the two groups of Hispanics. Significant associations were found among Puerto Ricans but not Mexicans.
57. Lee DK, Currie GP, Hall IP, et al. The arginine-16 beta2-adrenoceptor polymorphism predisposes to bronchoprotective subsensitivity in patients treated with formoterol and salmeterol. Br J Clin Pharmacol 2004; 57:68-75. This retrospective study found that patients who had the Arg16 allele were predisposed to greater degrees of airways hyperresponsiveness when exposed to long-acting b-agonists.
58. Sims EJ, Lipworth BJ. Concomitant occasional use of salbutamol influences bronchoprotective responsiveness afforded by formoterol in patients with the glycine-16 genotype. Eur J Clin Pharmacol 2004; 59:791-795. This retrospective study found that patients who were both homozygous for the Gly16 allele and were using a long-acting b-agonist were predisposed to greater degrees of airways hyperresponsiveness when they also used short-acting β-agonists.
59. Israel E, Chinchilli VM, Ford JG, et al. Use of regularly scheduled albuterol treatment in asthma: genotype-stratified, randomised, placebo-controlled cross-over trial. Lancet 2004; 364:1505-1512. This is the first genotype-stratified study of the effects of Arg16Gly on treatment related responses in asthma. Several interesting issues have been raised with regard to this study. In addition to these issues, replication of this study is needed.
60. Tattersfield AE, Hall IP. Are beta2-adrenoceptor polymorphisms important in asthma: an unravelling story. Lancet 2004; 364:1464-1466.
61. Drysdale CM, McGraw DW, Stack CB, et al. Complex promoter and coding region beta 2-adrenergic receptor haplotypes alter receptor expression and predict in vivo responsiveness. Proc Natl Acad Sci U S A 2000; 97:10483-10488.
62. Taylor DR, Epton MJ, Kennedy MA, et al. Bronchodilator response in relation to beta-adrenoceptor haplotype in patients with asthma. Am J Respir Crit Care Med 2005; [Epub ahead of print]. The authors analyze the eight SNPs that were studied by Drysdale et al., and do not find an association with bronchodilator response.
63. Tantisira KG, Small KM, Litonjua AA, et al. Molecular properties and pharmacogenetics of a polymorphismof adenylyl cyclase type 9 in asthma: interaction between beta-agonist and corticosteroid pathways. Hum Mol Genet 2005; 14:1671-1677. This was the first study to suggest a potential interaction between ADRB2 and the AC9 gene.